US University started a clinical trcil of Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
Thomas Jefferson University is commencing recruitment for the clinical trial of the Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer.
The condition is Head and Neck Carcinoma.
This trial studies the effects of human papillomavirus diagnosis on the relationships of patients with head and neck cancer. Determining the effects of human papillomavirus diagnosis on relationships may determine whether human papillomavirus-positive patients and their partners are more likely to experience decline in relationship intimacy after diagnosis than human papillomavirus-negative patients and their partners. This may help researchers provide valuable insight into the degree to which a diagnosis of human papillomavirus affects patient relationships over and above the effects of a cancer diagnosis and address the need for additional patient counseling or education following diagnosis.
Among the criteria that allow participation, the following are indicated:
- Diagnosis of head and neck cancer (previously untreated, any stage) or in a partnered relationship with an individual diagnosed with head and neck cancer
- Tumors positive for HPV
- Tumors negative for HPV
- Treatment plan is intent to cure
- In a partnered relationship
- Willing to answer brief survey prior to treatment and again after completion of treatment
A new clinical trial is recruiting patients in the following locations: United States.
The trial officially began on the January 24, 2020 and is planned to complete on July 23, 2022.
The link to the complete study profile: The link to the complete study profile: https://ichgcp.net/clinical-trials-registry/NCT04666428
